USH2A p.Pro2149Gln
c.6446C>A · rs869312182 · VCV224753
ClinGen expert panel — Hearing Loss VCEP
Uncertain Significance for Usher syndrome. Applied ACMG criteria (verbatim):
PM2_Supporting PP4 PM3
Curation rationale (ClinGen, verbatim)
The NM_206933.4:c.6446C>A variant in the USH2A gene is a missense variant predicted to cause the substitution of proline by glutamine at amino acid 2149 (p.Pro2149Gln). The minor allele frequency of this variant in gnomAD v.4.1.0 was 0.00059% (7/1179718 alleles) in the European (non-Finnish) population meeting PM2_Supporting. The REVEL computational prediction analysis tool produced a score of 0.355, which doesn’t meet either of the thresholds necessary to apply PP3/BP4. It has been detected with another suspected pathogenic variant in two patients with Usher syndrome type 2, of which one patient displayed hearing loss with an onset in the first decade and retinitis pigmentosa with an onset at 22y.o, which is specific for Usher syndrome (PM3, PP4; PMIDs: 26872967, 29074561, 32176120, 31836858). In summary, this variant meets criteria to be classified as variant of uncertain significance for autosomal recessive Usher syndrome based on the ACMG/AMP criteria applied as specified by the ClinGen Hearing Loss Expert Panel: PM3, PM2_Supporting, PP4 (ClinGen Hearing Loss VCEP specifications version 2; 4/16/2025).
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.7404 | likely pathogenic · top 7% in USH2A |
|---|---|---|
| REVEL | 0.355 | indeterminate |
| SaProt | — | not scored · why |
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 1.5, phastCons 1 |
| Regional constraint | o/e 1.05 | unconstrained · MANE · 797 kb · p 0.00011 · regional, not allelic |
| Overall | ||
| CADD | 22.4 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- USH2A
- Protein
- p.Pro2149Gln
- Coding
- c.6446C>A
- MANE Select
- NM_206933
- dbSNP
- rs869312182
- Type
- single nucleotide variant
- Location
- chr1:216000442 (GRCh38)
- Gene constraint
- LOEUF 0.855 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Residue 2149
- the fibronectin type-iii 8 domain
Disease context
Usher syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Usher syndrome type 2Ainherited retinal dystrophyretinitis pigmentosa
For Usher syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 100 000 (Worldwide)
Similar variants
- USH2A p.Pro2149= Likely benign ★ same residue
- USH2A c.12295-3T>A Pathogenic ★★★ same condition
- USH2A c.8559-2A>G Pathogenic ★★★ same condition
- USH2A c.8682-9A>G Pathogenic ★★★ same condition
- USH2A p.Ala4740Asp Pathogenic ★★★ ⚠ same condition
- USH2A p.Arg3905Cys Pathogenic ★★★ ⚠ same condition
- USH2A p.Arg4192Cys Likely pathogenic ★★★ ⚠ same condition
- USH2A p.Asn346His Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ush2a-p-pro2149gln (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown